{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:21Z","timestamp":1791860781503,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["ALF 20100305"],"award-info":[{"award-number":["ALF 20100305"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["K2008-62x-14647-06-3"],"award-info":[{"award-number":["K2008-62x-14647-06-3"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["K2010-61X-21569-01-1"],"award-info":[{"award-number":["K2010-61X-21569-01-1"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["K2010-61P-21568-01-4"],"award-info":[{"award-number":["K2010-61P-21568-01-4"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brain Foundation"},{"name":"S\u00f6derberg Foundation"},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008736","name":"M\u00e4rta Lundqvists Stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbi.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T04:15:12Z","timestamp":1413260112000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"Anniella","family":"Isgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette G.M.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Sellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2014.10.001_b0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2014.10.001_b0010","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2014.10.001_b0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2014.10.001_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00406-012-0327-6","article-title":"Chemokines in bipolar disorder: trait or state?","volume":"263","author":"Barbosa","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2014.10.001_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2014.10.001_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.10.001_b0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1742-2094-9-242","article-title":"Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study","volume":"9","author":"Bromander","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2014.10.001_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.intimp.2011.11.011","article-title":"Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils","volume":"12","author":"Chen","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2014.10.001_b0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/08923973.2013.828744","article-title":"Regulation of macrophage immune responses by antipsychotic drugs","volume":"35","author":"Chen","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"2","key":"10.1016\/j.bbi.2014.10.001_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.diabres.2012.09.003","article-title":"The linkage between inflammation and Type 2 diabetes mellitus","volume":"99","author":"Cruz","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbi.2014.10.001_b0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2014.10.001_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.10.001_b0070","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","article-title":"The activation of monocyte and T cell networks in patients with bipolar disorder","volume":"25","author":"Drexhage","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.10.001_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02592351","article-title":"Preanalytical factors and the measurement of cytokines in human subjects","volume":"26","author":"Dugue","year":"1996","journal-title":"Int J Clin Lab. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0080","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2014.10.001_b0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-5728(98)00192-1","article-title":"CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum","volume":"92","author":"Giovannelli","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2014.10.001_b0090","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3956(99)00021-7","article-title":"Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis","volume":"33","author":"Haack","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2010.02.133","article-title":"Exercise-induced release of cytokines in patients with major depressive disorder","volume":"126","author":"Hallberg","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2014.10.001_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2014.10.001_b0110","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2012.231","article-title":"Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder","volume":"38","author":"Jakobsson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2014.10.001_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2014.10.001_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2004.08.005","article-title":"T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients","volume":"129","author":"Kim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbi.2005.12.002","article-title":"Aerobic exercise, but not flexibility\/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults","volume":"20","author":"Kohut","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.10.001_b0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","article-title":"Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production","volume":"17","author":"Kossmann","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbi.2014.10.001_b0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archpsyc.1982.04290080001001","article-title":"Best estimate of lifetime psychiatric diagnosis: a methodological study","volume":"39","author":"Leckman","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jnr.10253","article-title":"Cytokines, chemokines, and cytokine receptors in human microglia","volume":"69","author":"Lee","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder","volume":"35","author":"Lehto","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2014.10.001_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","article-title":"Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor","volume":"54","author":"Maes","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002130050965","article-title":"In vitro immunoregulatory effects of lithium in healthy volunteers","volume":"143","author":"Maes","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2014.10.001_b0170","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1089\/neu.2005.22.822","article-title":"Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study","volume":"22","author":"Maier","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbi.2014.10.001_b0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymeth.2012.03.017","article-title":"Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases (San Diego, Calif.)","volume":"56","author":"Malekzadeh","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.bbi.2014.10.001_b0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2014.10.001_b0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2014.10.001_b0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2014.10.001_b0205","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1074\/jbc.M109711200","article-title":"Lithium induces NF-kappa B activation and interleukin-8 production in human intestinal epithelial cells","volume":"277","author":"Nemeth","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2014.10.001_b0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O\u2019Brien","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2014.10.001_b0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","article-title":"The effects of lithium on ex vivo cytokine production","volume":"50","author":"Rapaport","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0220","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1176\/ajp.154.12.1726","article-title":"Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure","volume":"154","author":"Roy","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0447.2009.01399.x","article-title":"A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD","volume":"120","author":"Ryden","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2014.10.001_b0230","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","article-title":"Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"53","author":"Sachs","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0235","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.bbi.2014.10.001_b0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","article-title":"Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks","volume":"30","author":"Semple","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"Suppl. 20","key":"10.1016\/j.bbi.2014.10.001_b0245","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.10.001_b0255","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in Major Depressive Disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2014.10.001_b0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(98)00025-1","article-title":"The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression","volume":"49","author":"Song","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2014.10.001_b0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","article-title":"Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies","volume":"42","author":"Stuart","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2014.10.001_b0270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/NEN.0b013e318197eca7","article-title":"Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis","volume":"68","author":"Subileau","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2014.10.001_b0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder","volume":"36","author":"S\u00f6derlund","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2014.10.001_b0280","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S0029665110001928","article-title":"Physical activity, exercise and low-grade systemic inflammation","volume":"69","author":"Warnberg","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.bbi.2014.10.001_b0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","article-title":"Monocyte chemoattractant protein-1 and the blood\u2013brain barrier","volume":"71","author":"Yao","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2014.10.001_b0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2014.03.045","article-title":"Blood\u2013cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","volume":"217","author":"Zetterberg","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2014.10.001_b0295","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia","volume":"65","author":"Zhang","year":"2004","journal-title":"J. Clin. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:38:18Z","timestamp":1760168298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114004747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":59,"alternative-id":["S0889159114004747"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.10.001","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}